|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:activities
|
broad-spectrum
|
|
gptkbp:application
|
topical application
|
|
gptkbp:approves
|
gptkb:FDA
1950s
|
|
gptkbp:availability
|
widely available
|
|
gptkbp:available_on
|
prescription medication
|
|
gptkbp:brand
|
gptkb:Sulfamylon_Cream
|
|
gptkbp:category
|
gptkb:C
|
|
gptkbp:class
|
gptkb:pharmaceuticals
gptkb:Bastiladon
|
|
gptkbp:clinical_trial
|
studied for efficacy in burn treatment
|
|
gptkbp:clinical_use
|
used in burn units
|
|
gptkbp:community_service
|
safe for children
|
|
gptkbp:contraindication
|
hypersensitivity to sulfonamides
|
|
gptkbp:dosage_form
|
gptkb:cream
|
|
gptkbp:formulation
|
gptkb:cream
gptkb:Antihero
|
|
gptkbp:formulation_strength
|
5% cream
|
|
gptkbp:healthcare
|
topical agent
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sulfamylon
|
|
gptkbp:incompatibilities
|
avoid contact with eyes
|
|
gptkbp:indication
|
prevention of infection in burn wounds
|
|
gptkbp:ingredients
|
gptkb:mafenide_acetate
|
|
gptkbp:interacts_with
|
may interact with other topical agents
|
|
gptkbp:is_monitored_by
|
watch for signs of infection
|
|
gptkbp:lifespan
|
gptkb:unknown
|
|
gptkbp:manufacturer
|
various pharmaceutical companies
|
|
gptkbp:mechanism_of_action
|
inhibits bacterial folic acid synthesis
|
|
gptkbp:packaging
|
tube
|
|
gptkbp:patient_education
|
apply to clean, dry skin
|
|
gptkbp:pharmacokinetics
|
absorbed through the skin
|
|
gptkbp:provides_guidance_on
|
recommended for burn care
|
|
gptkbp:route_of_administration
|
topical
|
|
gptkbp:safety_features
|
generally well tolerated
|
|
gptkbp:safety_measures
|
use in patients with renal impairment
|
|
gptkbp:shelf_life
|
2 years
|
|
gptkbp:side_effect
|
allergic reaction
rash
itching
burning sensation
methemoglobinemia
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:trade
|
gptkb:Sulfamylon
|
|
gptkbp:used_for
|
treatment of burns
|
|
gptkbp:bfsParent
|
gptkb:sulfanilamide
|
|
gptkbp:bfsLayer
|
7
|